• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Ovarian Cysts Companies

    ID: MRFR/Pharma/1252-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Ovarian cysts companies focus on providing medical solutions for the diagnosis and management of ovarian cysts, fluid-filled sacs that can develop within the ovaries. These companies contribute to women's health by offering diagnostic imaging technologies, medications, and minimally invasive surgical interventions to address ovarian cysts and associated symptoms. Their goal is to provide effective and personalized care for individuals with ovarian cysts.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Ovarian Cysts Market Research Report – Forecast till 2034 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Ovarian Cysts Market

    Ovarian Cysts Key Companies

     


    Latest Ovarian Cysts Companies Update:

    Jan 2024Johnson & Johnson Announced the initiation of a Phase 2 clinical trial to evaluate the efficacy and safety of their investigational drug candidate, CD40 ligand (CD40L) antagonist, for the treatment of women with persistent ovarian cysts who are at risk for developing ovarian cancer. Emphasized their commitment to developing innovative therapies for women's health conditions, including ovarian cyst management.


    Abbott Laboratories Launched their Lucira™ Ovarian Cyst Test, a point-of-care blood test that helps distinguish between benign and malignant ovarian cysts, potentially reducing unnecessary surgeries and anxiety for patients. Focused on developing diagnostic tools that improve the accuracy and efficiency of ovarian cyst evaluation.


    Olympus Corporation Received FDA clearance for their SonoGuide™ Hybrid Imaging System, combining ultrasound and photoacoustic imaging technology, offering improved visualization and characterization of ovarian cysts during minimally invasive procedures. Partnered with research institutions to further develop and refine advanced imaging technologies for women's health applications.


    Medtronic Expanded their portfolio of surgical instruments with the launch of the EnSeal™ G2 Tissue Sealer, offering a minimally invasive option for ovarian cyst removal and potentially reducing blood loss and postoperative complications. Focused on developing innovative surgical technologies that enhance the safety and efficacy of ovarian cyst management procedures.


    Myovant Sciences Ltd Presented positive Phase 3 data for their investigational oral contraceptive, Mylena®, demonstrating its effectiveness in preventing ovulation and managing hormonal imbalances associated with ovarian cysts. Advocated for the role of hormonal control in preventing and managing ovarian cysts, potentially reducing the need for surgical intervention.


    List of Ovarian Cysts companies in the market

    • Pfizer Inc.

    • Teva Pharmaceutical Industries Ltd

    • Quest Diagnostics Incorporated

    • Novartis AG

    • General Electric Company

    • Merck & Co. Inc

    • Boston Scientific Corporation

    • Medtronic